Current Research Old | Microbiota Therapeutics

CURRENT RESEARCH AT THE UNIVERSITY OF MINNESOTA

Leukemia

The University of Minnesota Masonic Cancer Center is recruiting patients for an IMT clinical trial to understand the clinical efficacy of IMT treatment for patients with acute myeloid leukemia and patients receiving allogenic hematopoietic stem cell transplants.

Ulcerative Colitis

We are currently recruiting patients with ulcerative colitis for an intestinal microbiota transplant clinical research study.

RESEARCH SUPPORTED BY MICROBIOTA THERAPEUTICS PROGRAM

Recurrent C. difficile

The U.S. Department of Veterans Affairs is studying the efficacy of IMT for the prevention of recurrent C. difficile infection (CDI) after treatment of recurrent CDI with standard antimicrobial therapy.

VA Office of Research and Development

C. difficile in Solid Organ Transplant Recipients

Studying the effects of intestinal microbiota transplant in solid organ transplant recipients who have a C. difficile infection. University of Wisconsin, Madison, PI: Nasia Safdar, MD, PhD